| Bioactive Compounds and Antitumor Agents | Lifetime | 28 | KR 2 | 99.41 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 39 | KR 2 | 99.30 |
| Natural product bioactivities and synthesis | Lifetime | 77 | KR 9 | 99.39 |
| Healthcare and Venom Research | Lifetime | 44 | KR 6 | 98.89 |
| Bioactive natural compounds | Lifetime | 17 | KR 3 | 98.87 |
| Garlic and Onion Studies | Lifetime | 24 | KR 1 | 98.65 |
| Berberine and alkaloids research | Lifetime | 25 | KR 1 | 98.25 |
| Cancer-related Molecular Pathways | Lifetime | 250 | KR 3 | 99.03 |
| Cell death mechanisms and regulation | Lifetime | 127 | KR 1 | 98.88 |
| Pharmacological Effects of Natural Compounds | Lifetime | 228 | KR 17 | 98.16 |
| Plant-derived Lignans Synthesis and Bioactivity | Lifetime | 24 | KR 3 | 97.51 |
| Fungal Biology and Applications | Lifetime | 231 | KR 6 | 98.34 |
| Phytochemical and Pharmacological Studies | Lifetime | 22 | KR 2 | 96.80 |
| Autophagy in Disease and Therapy | Lifetime | 265 | KR 4 | 98.06 |
| NF-κB Signaling Pathways | Lifetime | 164 | KR 3 | 98.18 |
| Cancer Research and Treatments | Lifetime | 400 | KR 4 | 97.79 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 44 | KR 1 | 96.17 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 189 | KR 6 | 97.49 |
| Retinoids in leukemia and cellular processes | Lifetime | 270 | KR 2 | 97.50 |
| Seaweed-derived Bioactive Compounds | Lifetime | 132 | KR 16 | 97.46 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 125 | KR 3 | 97.11 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 718 | KR 13 | 97.76 |
| Heterocyclic Compound Synthesis and Bioactivity | Lifetime | 759 | KR 6 | 96.70 |
| Histone Deacetylase Inhibitors Research | Lifetime | 334 | KR 3 | 96.83 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 73 | KR 1 | 96.43 |
| Inflammatory mediators and NSAID effects | Lifetime | 544 | KR 5 | 96.99 |
| Phytochemical Studies and Bioactivities | Lifetime | 110 | KR 1 | 96.62 |
| Cancer, Lipids, and Metabolism | Lifetime | 868 | KR 10 | 97.02 |
| Synthesis of Organic Compounds | Lifetime | 344 | KR 4 | 96.00 |
| Flavonoids in Medical Research | Lifetime | 85 | KR 9 | 95.12 |
| Cancer therapeutics and mechanisms | Lifetime | 981 | KR 9 | 95.52 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 644 | KR 18 | 95.08 |
| Ginger and Zingiberaceae research | Lifetime | 167 | KR 11 | 93.02 |
| Traditional Chinese Medicine Analysis | Lifetime | 464 | KR 19 | 93.93 |
| Phytochemical compounds biological activities | Lifetime | 371 | KR 5 | 94.26 |
| Curcumin's Biomedical Applications | Lifetime | 295 | KR 12 | 92.88 |
| Glutathione Transferases and Polymorphisms | Lifetime | 513 | KR 13 | 93.36 |
| Ginseng Biological Effects and Applications | Lifetime | 620 | KR 145 | 91.93 |
| Quinazolinone synthesis and applications | Lifetime | 716 | KR 16 | 90.65 |
| Bioactive Natural Diterpenoids Research | Lifetime | 201 | KR 3 | 90.65 |
| Phytochemistry and Bioactive Compounds | Lifetime | 396 | KR 15 | 90.31 |
| Barrier Structure and Function Studies | Lifetime | 544 | KR 5 | 90.47 |
| Medicinal plant effects and applications | Lifetime | 313 | KR 8 | 87.80 |
| Telomeres, Telomerase, and Senescence | Lifetime | 876 | KR 17 | 89.26 |
| Herbal Medicine Research Studies | Lifetime | 348 | KR 11 | 86.52 |
| Phytochemistry and Bioactivity Studies | Lifetime | 435 | KR 9 | 85.94 |
| Tannin, Tannase and Anticancer Activities | Lifetime | 210 | KR 10 | 86.93 |
| Macrophage Migration Inhibitory Factor | Lifetime | 633 | KR 11 | 85.13 |
| Silymarin and Mushroom Poisoning | Lifetime | 283 | KR 12 | 81.47 |
| Nephrotoxicity and Medicinal Plants | Lifetime | 649 | KR 13 | 71.31 |
| Biological Stains and Phytochemicals | Lifetime | 313 | KR 10 | 70.38 |
| Magnolia and Illicium research | Lifetime | 386 | KR 53 | 62.90 |
| Mangiferin and Mango Extracts | Lifetime | 301 | KR 4 | 59.73 |
| Bioactive Compounds in Plants | Lifetime | 655 | KR 47 | 45.92 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 18 | KR 1 | 96.26 |
| Natural product bioactivities and synthesis | 2021-2025 | 66 | KR 1 | 96.03 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 64 | KR 3 | 95.76 |
| Cell death mechanisms and regulation | 2021-2025 | 47 | KR 2 | 89.83 |
| Inflammasome and immune disorders | 2021-2025 | 466 | KR 7 | 88.26 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 89 | KR 3 | 87.11 |
| Retinal Diseases and Treatments | 2021-2025 | 994 | KR 47 | 91.33 |
| Bone Metabolism and Diseases | 2021-2025 | 259 | KR 16 | 86.29 |
| Biological Stains and Phytochemicals | 2021-2025 | 15 | KR 1 | 78.78 |
| Immune Response and Inflammation | 2021-2025 | 561 | KR 7 | 81.37 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 334 | KR 24 | 82.63 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 452 | KR 7 | 79.20 |
| Phytochemistry and Biological Activities | 2021-2025 | 934 | KR 21 | 81.06 |
| Antioxidant Activity and Oxidative Stress | 2021-2025 | 554 | KR 11 | 74.90 |
| Flavonoids in Medical Research | 2021-2025 | 119 | KR 11 | 71.42 |
| Biochemical and Molecular Research | 2021-2025 | 537 | KR 6 | 71.34 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 532 | KR 17 | 68.37 |
| Bioactive Compounds and Antitumor Agents | 2021-2025 | 599 | KR 14 | 67.56 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 500 | KR 21 | 66.48 |
| Magnolia and Illicium research | 2021-2025 | 38 | KR 3 | 66.32 |
| melanin and skin pigmentation | 2021-2025 | 894 | KR 107 | 67.80 |
| Bioactive natural compounds | 2021-2025 | 199 | KR 25 | 67.03 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 709 | KR 15 | 64.68 |
| Ginseng Biological Effects and Applications | 2021-2025 | 946 | KR 99 | 65.56 |
| Phytochemical Studies and Bioactivities | 2021-2025 | 272 | KR 3 | 59.90 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 778 | KR 25 | 56.80 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 892 | KR 13 | 54.59 |
| Plant-derived Lignans Synthesis and Bioactivity | 2021-2025 | 348 | KR 20 | 38.80 |
| Morinda citrifolia extract uses | 2021-2025 | 293 | KR 13 | 19.52 |
